ResMed Cash Beginning of Year Trend

ResMed Inc -- USA Stock  

USD 88.3  0.44  0.5%

This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.
Showing smoothed Cash Beginning of Year of ResMed Inc with missing and latest data points interpolated.
Cash Beginning of Year  10 Years Trend  
Increasing
Slightly volatile
 Cash Beginning of Year 
      Timeline 

ResMed Cash Beginning of Year Over Time

2016-12-31  717,249,000 
2017-12-31  717,249,000 
2018-12-31  843,822,353 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  617,307,335
Geometric Mean  560,820,523
Coefficient Of Variation  39.53
Mean Deviation  212,876,411
Median  717,249,000
Standard Deviation  244,042,592
Range  686,186,000
R Value  0.83
R Squared  0.69
Significance  0.00039923
Slope  52,236,951

Currently Trending

XLK   
 PCX 
Purchased over 100 shares of
few hours ago ago
Traded for 66.55
XLB   
 PCX 
Purchased over 100 shares of
few hours ago ago
Traded for 62.65
XLI   
 PCX 
Purchased over 100 shares of
few hours ago ago
Traded for 79.45